Dharti Proteins Receives Listing Approval for 5,00,000 Equity Shares Under NCLT Resolution Plan
Dharti Proteins Ltd has received listing approval from BSE Limited concerning a tranche of 5,00,000 equity shares, each valued at Rs. 10/-. This approval was granted by BSE Limited via letter dated June 16, 2026.The allotment of the shares is linked to an Approved Resolution plan sanctioned by the Hon'ble NCLT, Ahmedabad Bench in a resolution order dated November 18, 2025. The issuance details pertain to capital reduction and subsequent allocations under the approved plan.
A breakdown of the 5,00,000 equity shares allotted at Rs. 10/- is as follows:
| Allotment Type | Number of Shares | Share Value (Per Share) | Distinctive Number Range |
|---|---|---|---|
| Capital Reduction Allotment | 25,000 | Rs. 10/- | 1 - 25000 |
| SRA/Promoter Group Allocation | 4,25,000 | Rs. 10/- | N/A |
| Secured Financial Creditor Allotment | 50,000 | Rs. 10/- | 25001 - 500000 |
The company is currently executing the Corporate Action in coordination with National Stock Exchange (NSDL) and Central Depository Services Limited (CDSL). Management plans to apply for trading approval shortly after completing these processes.
Stock Price Movement
As of 15:18, Dharti Proteins Ltd maintains a stock price of ₹3.45, showing no change in its value today. The shares are trading completely flat, with the intraday high and low remaining precisely at that ₹3.45 mark.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.